| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by financing activities | 2 | 2 |
| Effect of exchange rates on cash, cash equivalents and restricted cash | 6,595 | 8,430 |
| Net decrease in cash, cash equivalents and restricted cash | -36,726 | -24,616 |
| Cash and cash equivalents at beginning of period | 112,400 | - |
| Cash and cash equivalents at end of period | 75,674 | - |
Barinthus Biotherapeutics plc. (BRNS)
Barinthus Biotherapeutics plc. (BRNS)